So, lots of words and bullish opinions given in response to my post but none has addressed where the money is coming from for the trial and what are the cost and the associated commercial conditions. To me and in my opinion it just looks like wishful thinking considering this is a risky small drug development company with a history of limping from capital raise to capital raise with the demonstrated adverse ongoing effect on the share price
KZA Price at posting:
49.5¢ Sentiment: Sell Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
